197 related articles for article (PubMed ID: 20071661)
1. 13q14 deletions in CLL involve cooperating tumor suppressors.
Palamarchuk A; Efanov A; Nazaryan N; Santanam U; Alder H; Rassenti L; Kipps T; Croce CM; Pekarsky Y
Blood; 2010 May; 115(19):3916-22. PubMed ID: 20071661
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel B-CLL candidate gene--DLEU7--located in the 13q14 tumor suppressor locus.
Hammarsund M; Corcoran MM; Wilson W; Zhu C; Einhorn S; Sangfelt O; Grandér D
FEBS Lett; 2004 Jan; 556(1-3):75-80. PubMed ID: 14706829
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of CLL.
Pekarsky Y; Zanesi N; Croce CM
Semin Cancer Biol; 2010 Dec; 20(6):370-6. PubMed ID: 20863894
[TBL] [Abstract][Full Text] [Related]
4. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia.
Migliazza A; Bosch F; Komatsu H; Cayanis E; Martinotti S; Toniato E; Guccione E; Qu X; Chien M; Murty VV; Gaidano G; Inghirami G; Zhang P; Fischer S; Kalachikov SM; Russo J; Edelman I; Efstratiadis A; Dalla-Favera R
Blood; 2001 Apr; 97(7):2098-104. PubMed ID: 11264177
[TBL] [Abstract][Full Text] [Related]
5. Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines.
Lia M; Carette A; Tang H; Shen Q; Mo T; Bhagat G; Dalla-Favera R; Klein U
Blood; 2012 Mar; 119(13):2981-90. PubMed ID: 22174151
[TBL] [Abstract][Full Text] [Related]
6. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway.
Endo T; Nishio M; Enzler T; Cottam HB; Fukuda T; James DF; Karin M; Kipps TJ
Blood; 2007 Jan; 109(2):703-10. PubMed ID: 16973958
[TBL] [Abstract][Full Text] [Related]
7. Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia.
Liu Y; Corcoran M; Rasool O; Ivanova G; Ibbotson R; Grandér D; Iyengar A; Baranova A; Kashuba V; Merup M; Wu X; Gardiner A; Mullenbach R; Poltaraus A; Hultström AL; Juliusson G; Chapman R; Tiller M; Cotter F; Gahrton G; Yankovsky N; Zabarovsky E; Einhorn S; Oscier D
Oncogene; 1997 Nov; 15(20):2463-73. PubMed ID: 9395242
[TBL] [Abstract][Full Text] [Related]
8. Novel insights in molecular mechanisms of CLL.
Zanesi N; Balatti V; Bottoni A; Croce CM; Pekarsky Y
Curr Pharm Des; 2012; 18(23):3363-72. PubMed ID: 22591386
[TBL] [Abstract][Full Text] [Related]
9. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
Stilgenbauer S; Nickolenko J; Wilhelm J; Wolf S; Weitz S; Döhner K; Boehm T; Döhner H; Lichter P
Oncogene; 1998 Apr; 16(14):1891-7. PubMed ID: 9583687
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene.
Bullrich F; Fujii H; Calin G; Mabuchi H; Negrini M; Pekarsky Y; Rassenti L; Alder H; Reed JC; Keating MJ; Kipps TJ; Croce CM
Cancer Res; 2001 Sep; 61(18):6640-8. PubMed ID: 11559527
[TBL] [Abstract][Full Text] [Related]
11. Deletions in the 13q14 locus in adult lymphoblastic leukemia: rate of incidence and relevance.
Chung CY; Kantarjian H; Haidar M; Starostik P; Manshouri T; Gidel C; Freireich E; Keating M; Albitar M
Cancer; 2000 Mar; 88(6):1359-64. PubMed ID: 10717617
[TBL] [Abstract][Full Text] [Related]
12. Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia.
Lin K; Farahani M; Yang Y; Johnson GG; Oates M; Atherton M; Douglas A; Kalakonda N; Pettitt AR
Br J Haematol; 2014 Nov; 167(3):346-55. PubMed ID: 25040181
[TBL] [Abstract][Full Text] [Related]
13. A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions.
Tolomeo D; Agostini A; Solimando AG; Cunsolo CL; Cimarosto L; Palumbo O; Palumbo P; Carella M; Hernández-Sánchez M; Hernández-Rivas JM; Storlazzi CT
Cancer Genet; 2023 Apr; 272-273():16-22. PubMed ID: 36641997
[TBL] [Abstract][Full Text] [Related]
14. Exclusion of Leu1 and Leu2 genes as tumor suppressor genes in 13q14.3-deleted B-CLL.
Rondeau G; Moreau I; Bézieau S; Cadoret E; Moisan JP; Devilder MC
Leukemia; 1999 Oct; 13(10):1630-2. PubMed ID: 10516767
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20.
Herold T; Jurinovic V; Mulaw M; Seiler T; Dufour A; Schneider S; Kakadia PM; Feuring-Buske M; Braess J; Spiekermann K; Mansmann U; Hiddemann W; Buske C; Bohlander SK
Genes Chromosomes Cancer; 2011 Jul; 50(7):546-58. PubMed ID: 21500311
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia.
Xu ZS; Zhang JS; Zhang JY; Wu SQ; Xiong DL; Chen HJ; Chen ZZ; Zhan R
Oncol Rep; 2015 Apr; 33(4):1609-14. PubMed ID: 25633905
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB.
Garding A; Bhattacharya N; Claus R; Ruppel M; Tschuch C; Filarsky K; Idler I; Zucknick M; Caudron-Herger M; Oakes C; Fleig V; Keklikoglou I; Allegra D; Serra L; Thakurela S; Tiwari V; Weichenhan D; Benner A; Radlwimmer B; Zentgraf H; Wiemann S; Rippe K; Plass C; Döhner H; Lichter P; Stilgenbauer S; Mertens D
PLoS Genet; 2013 Apr; 9(4):e1003373. PubMed ID: 23593011
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL--a preliminary study on a Polish population.
Jasek M; Wagner M; Sobczynski M; Wolowiec D; Kuliczkowski K; Woszczyk D; Kielbinski M; Kusnierczyk P; Frydecka I; Karabon L
Tissue Antigens; 2015 Oct; 86(4):279-84. PubMed ID: 26268376
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis.
Munzert G; Kirchner D; Stobbe H; Bergmann L; Schmid RM; Döhner H; Heimpel H
Blood; 2002 Nov; 100(10):3749-56. PubMed ID: 12411322
[TBL] [Abstract][Full Text] [Related]
20. 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.
Dal Bo M; Rossi FM; Rossi D; Deambrogi C; Bertoni F; Del Giudice I; Palumbo G; Nanni M; Rinaldi A; Kwee I; Tissino E; Corradini G; Gozzetti A; Cencini E; Ladetto M; Coletta AM; Luciano F; Bulian P; Pozzato G; Laurenti L; Forconi F; Di Raimondo F; Marasca R; Del Poeta G; Gaidano G; Foà R; Guarini A; Gattei V
Genes Chromosomes Cancer; 2011 Aug; 50(8):633-43. PubMed ID: 21563234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
